Pharma companies must safeguard against VAT fraud, says PwC Legal
13 May 2015 | By Victoria White
Pharma and medical supply companies have been earmarked by HMRC as a potential target for VAT fraud, but many are not yet attuned to the risk...
List view / Grid view
News
Fibromyalgia treatment market value to crawl to $1.9bn by 2023
13 May 2015 | By Victoria White
The treatment market value for fibromyalgia across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, will expand from $1.8 billion in 2013 at a tepid Compound Annual Growth Rate (CAGR) of 0.72% to reach $1.9 billion by 2023, according to research and consulting…
Cherwell appoints Operations Director to reinforce manufacturing expertise
13 May 2015 | By Cherwell Laboratories
Company focus on operational enhancements and maintenance of core values...
EIB supports Bavarian Nordic’s development of Ebola and cancer vaccines
13 May 2015 | By Victoria White
EIB has reaffirmed its commitment to respond to the Ebola pandemic by providing a EUR 50m loan to Bavarian Nordic for accelerated development of a vaccine...
UK pharma businesses should start assessing the Brexit effect, says Hogan Lovells
13 May 2015 | By Victoria White
Businesses, including those in the pharmaceutical sector, should start assessing the potential consequences of a Brexit, advises Hogan Lovells...
Bavarian Nordic announces positive results from pivotal Phase 3 study of IMVAMUNE smallpox vaccine
13 May 2015 | By Victoria White
Results from a Phase 3 study of the liquid-frozen formulation of IMVAMUNE support a Biologics License Application for US approval of the vaccine...
CPhI Worldwide announces strategic charity agreement with Global Angels
13 May 2015 | By Victoria White
CPhI Worldwide has launched a new partnership with charity Global Angels to help promote its efforts and encourage support from the pharmaceutical industry....
Actavis responds to SMC’s reccommendation of Ozurdex as a valuable treatment option for patients with diabetic macular oedema
13 May 2015 | By
Actavis has responded to the decision by the SMC to accept Ozurdex for use by NHS Scotland for the treatment of visual impairment in patients with DMO...
Baxter BioScience acquires Oncaspar portfolio for leukaemia for $900m
Baxter has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau for US $900 million.
Highland Therapeutics to present clinical data on its ADHD treatment at APA 2015
12 May 2015 | By Victoria White
Highland Therapeutics has announced that it will host a poster presentation highlighting Phase III clinical data for its ADHD treatment at APA 2015...
Muscular Dystrophy treatment pipeline offers hope for improved life expectancy, says GBI Research
12 May 2015 | By Victoria White
GBI Research reports on the highly diverse and innovative pipeline for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy treatment...
Seven partners “Hear” pharmaceutical lifecycle challenges together
12 May 2015 | By Klyo Collaborative
Seven companies have voluntarily come together to form a new collaborative problem-solving group, aimed at assisting biopharmaceutical companies solve their most pressing lifecycle pipeline problems...
FDA Fast Track designation for evofosfamide for treatment of patients living with advanced pancreatic cancer
12 May 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of evofosfamide for the treatment of patients with advanced pancreatic cancer...
Penn Pharma a PCI company, installs new Gerteis Roller Compactor Technology
12 May 2015 | By Penn Pharma
Pharmaceutical manufacturer Penn Pharma a PCI company, today announced the successful installation of the Gerteis Mini-Pactor at its contained manufacturing facility...
CPhI Istanbul 2015 opens as Turkey continues to dominate the MENA pharma region
12 May 2015 | By Victoria White
CPhI Istanbul (#cphiIstanbul), organised by UBM EMEA, will return to ICC Istanbul Congress Center, Istanbul, Turkey from 3 to 5 June 2015...
